The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)

被引：10

作者：

Wu, Wenming ^{[1
]}

Chen, Jie ^{[2
]}

Bai, Chunmei ^{[3
]}

Chi, Yihebali ^{[4
]}

Du, Yiqi ^{[5
]}

Feng, Shiting ^{[6
]}

Huo, Li ^{[7
]}

Jiang, Yuxin ^{[8
]}

Li, Jingnan ^{[9
]}

Lou, Wenhui ^{[10
]}

Luo, Jie ^{[11
]}

Shao, Chenghao ^{[12
]}

Shen, Lin ^{[13
]}

Wang, Feng ^{[14
]}

Wang, Liwei ^{[15
]}

Wang, Ou ^{[16
]}

Wang, Yu ^{[17
]}

Wu, Huanwen ^{[18
]}

Xing, Xiaoping ^{[16
]}

Xu, Jianming ^{[19
]}

Xue, Huadan ^{[20
]}

Xue, Ling ^{[21
]}

Yang, Yang ^{[22
]}

Yu, Xianjun ^{[23
]}

Yuan, Chunhui ^{[24
]}

Zhao, Hong ^{[25
]}

Zhu, Xiongzeng ^{[26
]}

Zhao, Yupei ^{[1
]}

机构：

[1] Peking Union Med Coll Hosp, Chinese Acad Med Sci & Peking Union Med Coll, Dept Gen Surg, State Key Lab Complex Severe & Rare Dis, Beijing, Peoples R China

[2] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China

[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Med Oncol, Beijing, Peoples R China

[4] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Canc Hosp, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China

[5] Navy Med Univ, Changhai Hosp Affiliated, Dept Ophthalmol, Shanghai 200433, Peoples R China

[6] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China

[7] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing Key Lab Mol Targeted Diag & Therapy Nucl, Dept Nucl Med, Beijing, Peoples R China

[8] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Ultrasound, Beijing, Peoples R China

[9] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gastroenterol, Beijing, Peoples R China

[10] Fudan Univ, Dept Gen Surg, Zhongshan Hosp, Qingpu Branch, Shanghai 200433, Peoples R China

[11] Beijing Hosp, Dept Pathol, Beijing, Peoples R China

[12] Navy Med Univ, Changzheng Hosp, Dept Pancreat Biliary Surg, Shanghai, Peoples R China

[13] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China

[14] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing, Jiangsu, Peoples R China

[15] Univ Sch Med, Renji Hosp, Dept Anaesthesiol, Shanghai Jiaotong, Shanghai, Peoples R China

[16] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Endocrinol, Beijing, Peoples R China

[17] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Guangdong, Peoples R China

[18] Chinese Acad Med Sci & Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Pathol, Beijing, Peoples R China

[19] Peoples Liberat Army Gen Hosp, Med Ctr 5, Dept Gastrointestinal Oncol, Beijing, Peoples R China

[20] Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing, Peoples R China

[21] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China

[22] Sun Yat Sen Univ, Affiliated Hosp 3, Liver Transplantat Ctr, Dept Hepat Surg, Guangzhou, Guangdong, Peoples R China

[23] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China

[24] Peking Univ Third Hosp, Dept Gen Surg, Beijing, Peoples R China

[25] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr, Dept Radiat Oncol,Canc Hosp, Beijing, Peoples R China

[26] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China

来源：

JOURNAL OF PANCREATOLOGY | 2021年 / 4卷 / 01期

关键词：

Diagnosis; Guidelines; Pancreatic Neuroendocrine Neoplasm; Treatment; ZOLLINGER-ELLISON-SYNDROME; ENETS CONSENSUS GUIDELINES; NEURON-SPECIFIC ENOLASE; PROTON PUMP INHIBITORS; CONTRAST-ENHANCED CT; INSTITUTES-OF-HEALTH; VOLUME PERFUSION CT; CHROMOGRANIN-A; LIVER METASTASES; SURGICAL-TREATMENT;

D O I：

10.1097/JP9.0000000000000064

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic neuroendocrine neoplasms (pNENs) are highly heterogeneous, and the management of pNENs patients can be intractable. To address this challenge, an expert committee was established on behalf of the Chinese Pancreatic Surgery Association, which consisted of surgical oncologists, gastroenterologists, medical oncologists, endocrinologists, radiologists, pathologists, and nuclear medicine specialists. By reviewing the important issues regarding the diagnosis and treatment of pNENs, the committee concluded evidence-based statements and recommendations in this article, in order to further improve the management of pNENs patients in China.

引用

页码：1 / 17

页数：17

共 176 条

[1] Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
Al-Hawary, Mahmoud M.
Francis, Isaac R.
Chari, Suresh T.
Fishman, Elliot K.
Hough, David M.
Lu, David S.
Macari, Michael
Megibow, Alec J.
Miller, Frank H.
Mortele, Koenraad J.
Merchant, Nipun B.
Minter, Rebecca M.
Tamm, Eric P.
Sahani, Dushyant V.
Simeone, Diane M.
[J]. GASTROENTEROLOGY, 2014, 146 (01) : 291 - +
[2] Hereditary pancreatic endocrine tumours
Alexakis, N
Connor, S
Ghaneh, P
Lombard, M
Smart, HL
Evans, J
Hughes, M
Garvey, CJ
Vora, J
Vinjamuri, S
Sutton, R
Neoptolemos, JP
[J]. PANCREATOLOGY, 2004, 4 (05) : 417 - 433
[3] Amin MB, 2017, AJCC cancer staging manual, Veighth
[4] [Anonymous], 2019, Digestive System Tumours. WHO Tumour series, V5th
[5] Can we predict recurrence in WHO G1-G2 pancreatic neuroendocrine neoplasms? Results from a multi-institutional Spanish study
Ausania, F.
Senra del Rio, P.
Gomez-Bravo, M. A.
Martin-Perez, E.
Perez-Daga, J. A.
Dorcaratto, D.
Gonzalez-Nicolas, T.
Sanchez-Cabus, S.
Tardio-Baiges, A.
[J]. PANCREATOLOGY, 2019, 19 (02) : 367 - 371
[6] Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
Bajetta, Emilio
Catena, Laura
Procopio, Giuseppe
De Dosso, Sara
Bichisao, Ettore
Ferrari, Leonardo
Martinetti, Antonia
Platania, Marco
Verzoni, Elena
Formisano, Barbara
Bajetta, Roberto
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (05) : 637 - 642
[7] Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit
Barrett, James R.
Rendell, Victoria
Pokrzywa, Courtney
Lopez-Aguiar, Alexandra G.
Cannon, John
Poultsides, George A.
Rocha, Flavio
Crown, Angelena
Beal, Eliza
Michael Pawlik, Timothy
Fields, Ryan
Panni, Roheena Z.
Smith, Paula
Idrees, Kamran
Cho, Clifford
Beems, Megan
Maithel, Shishir
Weber, Sharon
Erik Abbott, Daniel
[J]. JOURNAL OF SURGICAL ONCOLOGY, 2020, 121 (07) : 1067 - 1073
[8] Impact of chromogranin A measurement in the work-up of neuroendocrine tumors
Baudin, E
Bidart, JM
Bachelot, A
Ducreux, M
Elias, D
Ruffié, P
Schlumberger, M
[J]. ANNALS OF ONCOLOGY, 2001, 12 : S79 - S82
[9] Serum gastrin in Zollinger-Ellison Syndrome - I. Prospective study of fasting serum gastrin in 309 patients from National Institutes of Health and Comparison with 2229 cases from the literature
Berna, Marc J.
Hoffmann, K. Martin
Serrano, Jose
Gibril, Fathia
Jensen, Robert T.
[J]. MEDICINE, 2006, 85 (06) : 295 - 330
[10] Serum gastrin in Zollinger-Ellison Syndrome - II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and Comparison with 537 cases from hte literature. Evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features
Berna, Marc J.
Hoffmann, K. Martin
Long, Scott H.
Serrano, Jose
Gibril, Fathia
Jensen, Robert T.
[J]. MEDICINE, 2006, 85 (06) : 331 - 364

← 1 2 3 4 5 6 7 8 9 10 →